Essential medicines for universal health coverage von Wirtz, Veronika J, Dr, Hogerzeil, Hans V, Prof, Gray, Andrew L, MSc, Bigdeli, Maryam, PhD, de Joncheere, Cornelis P, PharmD, Ewen, Margaret A, Dip Pharm, Gyansa-Lutterodt, Martha, MA, Jing, Sun, PhD, Luiza, Vera L, PhD, Mbindyo, Regina M, MBA, Möller, Helene, PhD, Moucheraud, Corrina, ScD, Pécoul, Bernard, MPH, Rägo, Lembit, PhD, Rashidian, Arash, Prof, Ross-Degnan, Dennis, ScD, Stephens, Peter N, PhD, Teerawattananon, Yot, PhD, t Hoen, Ellen F M, LLM, Wagner, Anita K, PhD, Yadav, Prashant, PhD, Reich, Michael R, Prof

Volltext

Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand von Leopold, Christine, Lu, Christine Y, Wagner, Anita K

Volltext

Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway von Shahzad, Mahnum, Naci, Huseyin, Wagner, Anita K

Volltext

Policies and programs to facilitate access to targeted cancer therapies in Thailand von Sruamsiri, Rosarin, Ross-Degnan, Dennis, Lu, Christine Y, Chaiyakunapruk, Nathorn, Wagner, Anita K

Volltext

Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China von Fang, Yu, Dr, Wagner, Anita K, DrPH, Yang, Shimin, BS, Jiang, Minghuan, MS, Zhang, Fang, PhD, Ross-Degnan, Dennis, ScD

Volltext

Estimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated Approval von Shahzad, Mahnum, Naci, Huseyin, Wagner, Anita K

Volltext

Newly approved cancer drugs in China — innovation and clinical benefit von Zhang, Yichen, Wagner, Anita K., Guan, Xiaodong

Volltext

Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway von Shahzad, Mahnum, Naci, Huseyin, Esselen, Katharine M, Dottino, Joseph A, Wagner, Anita K

Volltext

Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data: a retrospective analysis von Naci, Huseyin, Zhang, Yichen, Woloshin, Steven, Guan, Xiaodong, Xu, Ziyue, Wagner, Anita K

Volltext

Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries von LEAPALD, Christine, MANTEL-TEEUWISSE, Aukje K, VOGLER, Sabine, VALKOVA, Silvia, DE JONCHEERE, Kees, LEUFKENS, Hubert G. M, WAGNER, Anita K, ROSS-DEGNAN, Dennis, LAING, Richard

Volltext

How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid? von Hsu, Jason C., PhD, Ross-Degnan, Dennis, ScD, Wagner, Anita K., PharmD, DrPH, Zhang, Fang, PhD, Lu, Christine Y., MSc, PhD

Volltext

Simulation-based power calculation for designing interrupted time series analyses of health policy interventions von Zhang, Fang, Wagner, Anita K, Ross-Degnan, Dennis

Volltext

Availability and Use of Essential Medicines in China : Manufacturing, Supply, and Prescribing in Shandong and Gansu Provinces von Chen, W, Tang, S. L, Sun, J, Ross-Degnan, D, Wagner, A. K

Volltext

Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil von Ivama-Brummell, Adriana Mitsue, Wagner, Anita K, Pepe, Vera Lúcia Edais, Naci, Huseyin

Volltext

Communication of Survival Data in US Food and Drug Administration–Approved Labeling of Cancer Drugs von Naci, Huseyin, Guan, Xiaodong, Woloshin, Steven, Xu, Ziyue, Wagner, Anita K

Volltext

Payers’ experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems in North America, Europe, and Australasia von Morgan, Steven G, Vogler, Sabine, Wagner, Anita K

Volltext

Need for and access to health care and medicines: are there gender inequities? von Wagner, Anita K, Graves, Amy J, Fan, Zhengyu, Walker, Saul, Zhang, Fang, Ross-Degnan, Dennis

Volltext

1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities von Trap, Birna, Sembatya, Moses N., Imi, Monica, Seru, Morries, Wagner, Anita K., Ross-Degnan, Dennis

Volltext

Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage von Morgan, Steven G, Leopold, Christine, Wagner, Anita K

Volltext

Thirty Years of Media Coverage on High Drug Prices in the United States—A Never-Ending Story or a Time for Change? von Leopold, Christine, PhD, MS, Chambers, James D., PhD, MPharm, Wagner, Anita K., PharmD, MPH, DrPH

Volltext